Cargando…
Of Mice and Monkeys: Neuroprotective Efficacy of the p38 Inhibitor BIRB 796 Depends on Model Duration in Experimental Glaucoma
Glaucoma is a group of optic neuropathies associated with aging and sensitivity to intraocular pressure (IOP). Early progression involves retinal ganglion cell (RGC) axon dysfunction that precedes frank degeneration. Previously we demonstrated that p38 MAPK inhibition abates axonal dysfunction and s...
Autores principales: | Lambert, Wendi S., Pasini, Silvia, Collyer, John W., Formichella, Cathryn R., Ghose, Purnima, Carlson, Brian J., Calkins, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7244559/ https://www.ncbi.nlm.nih.gov/pubmed/32444682 http://dx.doi.org/10.1038/s41598-020-65374-6 |
Ejemplares similares
-
BIRB796, an Inhibitor of p38 Mitogen-Activated Protein
Kinase, Inhibits Proliferation and Invasion in Glioblastoma Cells
por: Zhao, Linyao, et al.
Publicado: (2021) -
BIRB 796 has Distinctive Anti-inflammatory Effects on Different Cell Types
por: Ryoo, Soyoon, et al.
Publicado: (2013) -
BIRB796, the Inhibitor of p38 Mitogen-Activated Protein Kinase, Enhances the Efficacy of Chemotherapeutic Agents in ABCB1 Overexpression Cells
por: He, Dan, et al.
Publicado: (2013) -
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma
por: Lambert, Wendi S., et al.
Publicado: (2017) -
Towards A Microbead Occlusion Model of Glaucoma for a Non-Human Primate
por: Lambert, Wendi S., et al.
Publicado: (2019)